Drug intelligence / Profile preview

Recovit ORS

Development stage: Unknown
Lead developer: Pharma-Med
Modality: Small Molecules
Administration: Oral

Overview

Recovit ORS is an over-the-counter (OTC) oral rehydration solution developed by Pharma-Med. It is formulated as effervescent tablets intended to be dissolved in water for the replacement of fluids and electrolytes. The product is used as a supportive treatment for dehydration, typically resulting from diarrhea, vomiting, or excessive sweating. It contains a balanced mixture of salts (electrolytes) and glucose to facilitate the absorption of water and essential ions in the small intestine. Recovit ORS is marketed as a supportive consumer health product rather than a drug in active clinical development.

Brand names: Recovit ORSRECOVIT
Other names: RECOVIT ORS effervescent tablets

Targets

SLC5A1 (Sodium Glucose Cotransporter 1)

Beyond the preview

Go deeper on Recovit ORS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Recovit ORS.

Explore the full profile